Loading…
Seaweeds as potential therapeutic interventions for the metabolic syndrome
Seaweeds are a characteristic part of the traditional diet in countries such as Japan and Korea; these countries also have a lower prevalence of metabolic syndrome than countries such as the USA and Australia. This suggests that seaweeds may contain compounds that reduce the characteristic signs of...
Saved in:
| Published in: | Reviews in endocrine & metabolic disorders 2013-09, Vol.14 (3), p.299-308 |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c438t-370fd1b736ba0bb915670f8aa7b20a7065d1c7ed5e988e89af2050df9fdaf3f23 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c438t-370fd1b736ba0bb915670f8aa7b20a7065d1c7ed5e988e89af2050df9fdaf3f23 |
| container_end_page | 308 |
| container_issue | 3 |
| container_start_page | 299 |
| container_title | Reviews in endocrine & metabolic disorders |
| container_volume | 14 |
| creator | Kumar, Senthil Arun Brown, Lindsay |
| description | Seaweeds are a characteristic part of the traditional diet in countries such as Japan and Korea; these countries also have a lower prevalence of metabolic syndrome than countries such as the USA and Australia. This suggests that seaweeds may contain compounds that reduce the characteristic signs of obesity, diabetes, hypertension, fatty liver and inflammation in the metabolic syndrome. Potentially bioactive compounds from seaweeds include polysaccharides, peptides, pigments, minerals and omega-3 fatty acids. This review emphasises current research on these compounds in isolated cells, animal models and patients. Key problems for future research include chemical characterisation of the bioactive principles, defining pharmacological responses in all aspects of the metabolic syndrome, determining if a therapeutic dose has been administered, and defining oral bioavailability of the active ingredients. |
| doi_str_mv | 10.1007/s11154-013-9254-8 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1449282149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1449282149</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-370fd1b736ba0bb915670f8aa7b20a7065d1c7ed5e988e89af2050df9fdaf3f23</originalsourceid><addsrcrecordid>eNp1kMtKxDAUhoMozjj6AG6k4MZNNZemTZYiXhlwoa5D2p5oh7YZk1SZtzelo4jgKof837nwIXRM8DnBuLjwhBCepZiwVNJYiB00J7xgKc1xvhtrJmQqCeczdOD9CmNKcsn30YwyySXL6Bw9PIH-BKh9on2ytgH60Og2CW_g9BqG0FRJ0wdwH2Nge58Y68Y06SDo0rYx95u-draDQ7RndOvhaPsu0MvN9fPVXbp8vL2_ulymVcZESFmBTU3KguWlxmUZz8vjj9C6KCnWBc55TaoCag5SCBBSG4o5ro00tTbMULZAZ9PctbPvA_igusZX0La6Bzt4RbJMUkFJJiN6-gdd2cH18bpIsTzKKEQeKTJRlbPeOzBq7ZpOu40iWI2i1SRaRdFqFK1E7DnZTh7KDuqfjm-zEaAT4GPUv4L7tfrfqV-0-Yj8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1436695786</pqid></control><display><type>article</type><title>Seaweeds as potential therapeutic interventions for the metabolic syndrome</title><source>Springer Nature</source><creator>Kumar, Senthil Arun ; Brown, Lindsay</creator><creatorcontrib>Kumar, Senthil Arun ; Brown, Lindsay</creatorcontrib><description>Seaweeds are a characteristic part of the traditional diet in countries such as Japan and Korea; these countries also have a lower prevalence of metabolic syndrome than countries such as the USA and Australia. This suggests that seaweeds may contain compounds that reduce the characteristic signs of obesity, diabetes, hypertension, fatty liver and inflammation in the metabolic syndrome. Potentially bioactive compounds from seaweeds include polysaccharides, peptides, pigments, minerals and omega-3 fatty acids. This review emphasises current research on these compounds in isolated cells, animal models and patients. Key problems for future research include chemical characterisation of the bioactive principles, defining pharmacological responses in all aspects of the metabolic syndrome, determining if a therapeutic dose has been administered, and defining oral bioavailability of the active ingredients.</description><identifier>ISSN: 1389-9155</identifier><identifier>EISSN: 1573-2606</identifier><identifier>DOI: 10.1007/s11154-013-9254-8</identifier><identifier>PMID: 23959342</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Diabetes ; Endocrinology ; Humans ; Internal Medicine ; Medicine ; Medicine & Public Health ; Metabolic Syndrome - metabolism ; Metabolic Syndrome - prevention & control ; Metabolic Syndrome - therapy ; Peptides - chemistry ; Polysaccharides - chemistry ; Seaweed - chemistry</subject><ispartof>Reviews in endocrine & metabolic disorders, 2013-09, Vol.14 (3), p.299-308</ispartof><rights>Springer Science+Business Media New York 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-370fd1b736ba0bb915670f8aa7b20a7065d1c7ed5e988e89af2050df9fdaf3f23</citedby><cites>FETCH-LOGICAL-c438t-370fd1b736ba0bb915670f8aa7b20a7065d1c7ed5e988e89af2050df9fdaf3f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23959342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumar, Senthil Arun</creatorcontrib><creatorcontrib>Brown, Lindsay</creatorcontrib><title>Seaweeds as potential therapeutic interventions for the metabolic syndrome</title><title>Reviews in endocrine & metabolic disorders</title><addtitle>Rev Endocr Metab Disord</addtitle><addtitle>Rev Endocr Metab Disord</addtitle><description>Seaweeds are a characteristic part of the traditional diet in countries such as Japan and Korea; these countries also have a lower prevalence of metabolic syndrome than countries such as the USA and Australia. This suggests that seaweeds may contain compounds that reduce the characteristic signs of obesity, diabetes, hypertension, fatty liver and inflammation in the metabolic syndrome. Potentially bioactive compounds from seaweeds include polysaccharides, peptides, pigments, minerals and omega-3 fatty acids. This review emphasises current research on these compounds in isolated cells, animal models and patients. Key problems for future research include chemical characterisation of the bioactive principles, defining pharmacological responses in all aspects of the metabolic syndrome, determining if a therapeutic dose has been administered, and defining oral bioavailability of the active ingredients.</description><subject>Diabetes</subject><subject>Endocrinology</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Syndrome - metabolism</subject><subject>Metabolic Syndrome - prevention & control</subject><subject>Metabolic Syndrome - therapy</subject><subject>Peptides - chemistry</subject><subject>Polysaccharides - chemistry</subject><subject>Seaweed - chemistry</subject><issn>1389-9155</issn><issn>1573-2606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKxDAUhoMozjj6AG6k4MZNNZemTZYiXhlwoa5D2p5oh7YZk1SZtzelo4jgKof837nwIXRM8DnBuLjwhBCepZiwVNJYiB00J7xgKc1xvhtrJmQqCeczdOD9CmNKcsn30YwyySXL6Bw9PIH-BKh9on2ytgH60Og2CW_g9BqG0FRJ0wdwH2Nge58Y68Y06SDo0rYx95u-draDQ7RndOvhaPsu0MvN9fPVXbp8vL2_ulymVcZESFmBTU3KguWlxmUZz8vjj9C6KCnWBc55TaoCag5SCBBSG4o5ro00tTbMULZAZ9PctbPvA_igusZX0La6Bzt4RbJMUkFJJiN6-gdd2cH18bpIsTzKKEQeKTJRlbPeOzBq7ZpOu40iWI2i1SRaRdFqFK1E7DnZTh7KDuqfjm-zEaAT4GPUv4L7tfrfqV-0-Yj8</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Kumar, Senthil Arun</creator><creator>Brown, Lindsay</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20130901</creationdate><title>Seaweeds as potential therapeutic interventions for the metabolic syndrome</title><author>Kumar, Senthil Arun ; Brown, Lindsay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-370fd1b736ba0bb915670f8aa7b20a7065d1c7ed5e988e89af2050df9fdaf3f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Diabetes</topic><topic>Endocrinology</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Syndrome - metabolism</topic><topic>Metabolic Syndrome - prevention & control</topic><topic>Metabolic Syndrome - therapy</topic><topic>Peptides - chemistry</topic><topic>Polysaccharides - chemistry</topic><topic>Seaweed - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, Senthil Arun</creatorcontrib><creatorcontrib>Brown, Lindsay</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Reviews in endocrine & metabolic disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, Senthil Arun</au><au>Brown, Lindsay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seaweeds as potential therapeutic interventions for the metabolic syndrome</atitle><jtitle>Reviews in endocrine & metabolic disorders</jtitle><stitle>Rev Endocr Metab Disord</stitle><addtitle>Rev Endocr Metab Disord</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>14</volume><issue>3</issue><spage>299</spage><epage>308</epage><pages>299-308</pages><issn>1389-9155</issn><eissn>1573-2606</eissn><abstract>Seaweeds are a characteristic part of the traditional diet in countries such as Japan and Korea; these countries also have a lower prevalence of metabolic syndrome than countries such as the USA and Australia. This suggests that seaweeds may contain compounds that reduce the characteristic signs of obesity, diabetes, hypertension, fatty liver and inflammation in the metabolic syndrome. Potentially bioactive compounds from seaweeds include polysaccharides, peptides, pigments, minerals and omega-3 fatty acids. This review emphasises current research on these compounds in isolated cells, animal models and patients. Key problems for future research include chemical characterisation of the bioactive principles, defining pharmacological responses in all aspects of the metabolic syndrome, determining if a therapeutic dose has been administered, and defining oral bioavailability of the active ingredients.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>23959342</pmid><doi>10.1007/s11154-013-9254-8</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1389-9155 |
| ispartof | Reviews in endocrine & metabolic disorders, 2013-09, Vol.14 (3), p.299-308 |
| issn | 1389-9155 1573-2606 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1449282149 |
| source | Springer Nature |
| subjects | Diabetes Endocrinology Humans Internal Medicine Medicine Medicine & Public Health Metabolic Syndrome - metabolism Metabolic Syndrome - prevention & control Metabolic Syndrome - therapy Peptides - chemistry Polysaccharides - chemistry Seaweed - chemistry |
| title | Seaweeds as potential therapeutic interventions for the metabolic syndrome |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A43%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seaweeds%20as%20potential%20therapeutic%20interventions%20for%20the%20metabolic%20syndrome&rft.jtitle=Reviews%20in%20endocrine%20&%20metabolic%20disorders&rft.au=Kumar,%20Senthil%20Arun&rft.date=2013-09-01&rft.volume=14&rft.issue=3&rft.spage=299&rft.epage=308&rft.pages=299-308&rft.issn=1389-9155&rft.eissn=1573-2606&rft_id=info:doi/10.1007/s11154-013-9254-8&rft_dat=%3Cproquest_cross%3E1449282149%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c438t-370fd1b736ba0bb915670f8aa7b20a7065d1c7ed5e988e89af2050df9fdaf3f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1436695786&rft_id=info:pmid/23959342&rfr_iscdi=true |